CD262 Antibody, anti-human, APC 130-097-249 from Miltenyi Biotec

Product Specs
ItemCD262 Antibody, anti-human, APC
CompanyMiltenyi Biotec
Price $330.00Supplier Page View Company Product Page
Catalog Number130-097-249
Quantity100 tests in 1 mL
ApplicationsFlow cytometry
Conjugate/TagAPC
Reactivityhuman
Clonalitymonoclonal
TargetCD262
IsotypeIsotype Control Antibody, mouse IgG1
CloneDJR2-4
Hostmouse
FormatReagents are supplied in buffer containing stabilizer and 0.05% sodium azide
NCBI Full Gene NameTNF receptor superfamily member 10b
NCBI Gene AliasesCD262, DR5, KILLER, KILLER/DR5, TRAIL-R2, TRAILR2, TRICK2, TRICK2A, TRICK2B, TRICKB, ZTNFR9
Regulatory StatusFor research use only
Concentration1:11
Research AreaFor research use only
TypeAntibodies
Source/Expression Systemmouse

Local Office

Miltenyi Biotec Inc.

2303 Lindbergh Street

Auburn, CA 95602

United States

Phone: Phone: +1 530 888 8871
Toll Free: 800 FOR MACS
Fax: +1 530 888 8925

Email: macs@miltenyibiotec.com

International Office

Miltenyi Biotec B.V. & Co. KG

Friedrich-Ebert-Straße 68

51429 Bergisch Gladbach

Germany

Phone: +49 2204 8306-0
Fax: +49 2204 8306-235

Email: macs@miltenyibiotec.de

(1) 2-methoxy-5-amino-N-hydroxybenzamide sensitizes colon cancer cells to TRAIL-induced apoptosis by regulating death receptor 5 and survivin expressionMolecular cancer therapeuticsOctober 1, 2011Stolfi C, Caruso R, Franzè E, Rizzo A, Rotondi A, Monteleone I, Fantini MC, Pallone F, Monteleone G.

(4) TRAIL-transduced dendritic cells protect mice from acute graft-versus-host disease and leukemia relapseJournal of immunology (Baltimore, Md. : 1950)April 1, 2005Sato K, Nakaoka T, Yamashita N, Yagita H, Kawasaki H, Morimoto C, Baba M, Matsuyama T.

(6) TNF-related apoptosis-inducing ligand (TRAIL) frequently induces apoptosis in Philadelphia chromosome-positive leukemia cellsBloodMay 1, 2003Uno K, Inukai T, Kayagaki N, Goi K, Sato H, Nemoto A, Takahashi K, Kagami K, Yamaguchi N, Yagita H, et al.

(7) 2-methoxyestradiol up-regulates death receptor 5 and induces apoptosis through activation of the extrinsic pathwayCancer researchJanuary 15, 2003LaVallee TM, Zhan XH, Johnson MS, Herbstritt CJ, Swartz G, Williams MS, Hembrough WA, Green SJ, Pribluda VS.

(9) Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAILThe Journal of biological chemistryOctober 10, 1997MacFarlane M, Ahmad M, Srinivasula SM, Fernandes-Alnemri T, Cohen GM, Alnemri ES.

(10) TRAIL-R2: a novel apoptosis-mediating receptor for TRAILThe EMBO journalSeptember 1, 1997Walczak H, Degli-Esposti MA, Johnson RS, Smolak PJ, Waugh JY, Boiani N, Timour MS, Gerhart MJ, Schooley KA, Smith CA, et al.

(11) Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivationOncogeneJanuary 1, 0001"Shigeno M, Nakao K, Ichikawa T, Suzuki K, Kawakami A, Abiru S, Miyazoe S, Nakagawa Y, Ishikawa H, Hamasaki K, et al."

CD262 Antibody, anti-human, APC from Miltenyi Biotec